Viewing Study NCT01142232


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-01-01 @ 2:21 PM
Study NCT ID: NCT01142232
Status: COMPLETED
Last Update Posted: 2019-10-22
First Post: 2010-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
Sponsor: Attaya Suvannasankha
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None autologous stem cell transplantation View